When Nextracker went public two years ago, few investors expected it to triple so quickly.
But after such a run, is it too late to buy? Or is this “picks and shovels” play on the clean-energy revolution still undervalued?
Nextracker controls about a quarter of the global solar tracker market.
» Read more about: 1 Solar Sleeper Stock That Still Has Room to Shine »
IBM has been tinkering with quantum computing longer than most of today’s retail investors have even been in the market. For decades, the company’s message has been quantum is coming, and when it arrives, it will change everything from chemistry to finance. The problem? The finish line has always felt just out of reach, perpetually ten years away.
» Read more about: IBM’s Quantum Breakthrough Could Be a Turning Point »
Big Tech seems to have rediscovered its appetite for Intel, a company that for years has looked more like a laggard than a leader. Billions of dollars are suddenly flowing its way, and the roster of backers is eye-catching.
In the past few weeks alone, the U.S. government committed just shy of $9 billion for roughly a 10% equity stake,
Amazon doesn’t look like a traditional stock. It’s more like a portfolio hiding inside one ticker. The company spans multiple industries, each one a profit driver in its own right.
The most visible business is e-commerce. In the second quarter of 2025, Amazon pulled in $137 billion in sales.
What many investors miss is that over 60% of those sales now come from third-party sellers.
The SPDR S&P Retail ETF is up about 25% since April 1, putting it within reach of its all-time high from late 2021. That kind of pop isn’t happening in isolation.
Consumer sentiment, which had been stuck near recessionary levels for most of 2022–2023, has recovered to a three-year high in 2025, according to the University of Michigan’s surveys.
» Read more about: Could a Consumer Bull Market Supercharge Shopify? »
Inside operating rooms across the globe, a revolution has been underway, one led by Intuitive Surgical (NASDAQ: ISRG).
Over the past five years, the company has more than doubled its profits, yet many argue that it’s still in the early innings of growth.
Intuitive Surgical has more than doubled profits in five years.
» Read more about: Is This Robotics Firm a Giant In The Making? »
AI stocks have been on fire in 2025. After Oracle and other hyperscalers revealed record-breaking capital expenditures, most semiconductor names raced back toward all-time highs. Yet one company that sits at the very heart of chip production has been noticeably absent from the party, ASML.
Despite that enviable position, the stock hasn’t kept pace with the AI rally.
Chime Financial is one of the most talked-about fintech players, but it has had a rollercoaster ride since its June IPO. The stock ran up to $43 on its first day of trading, riding a wave of excitement around digital banking. Fast-forward to today, and shares have been clipped by almost 50%.
So the big question is can Chime regain momentum and reward patient investors?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
With a market cap north of $2.2 trillion, more than half the value of every cryptocurrency combined, Bitcoin is a financial phenomenon.
But one of its most outspoken champions, Strategy co-founder Michael Saylor, doesn’t think Bitcoin’s story has even started. In fact, his latest forecast makes today’s price tag look like pocket change.
» Read more about: Why Bitcoin’s Path to $1 Million May Be More Realistic Than You Think »